-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Na7QUXQ2IS9/J/qK7QkJeYYDWxbQv24A+utgxazVboGqVHkpVNXQ+m5UdXqqDqj2
 Sgm07tnZCHYlCzMj1Fba6Q==

<SEC-DOCUMENT>0000892251-04-001135.txt : 20041209
<SEC-HEADER>0000892251-04-001135.hdr.sgml : 20041209
<ACCEPTANCE-DATETIME>20041209163256
ACCESSION NUMBER:		0000892251-04-001135
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041207
FILED AS OF DATE:		20041209
DATE AS OF CHANGE:		20041209

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIDIAN BIOSCIENCE INC
		CENTRAL INDEX KEY:			0000794172
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				310888197
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		3471 RIVER HILLS DR
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45244
		BUSINESS PHONE:		5132713700

	MAIL ADDRESS:	
		STREET 1:		3471 RIVER HILLS DRIVE
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45244

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MERIDIAN DIAGNOSTICS INC
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BALLISH GREGORY S
		CENTRAL INDEX KEY:			0001276478

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14902
		FILM NUMBER:		041193702

	BUSINESS ADDRESS:	
		STREET 1:		3471 RIVER HILLS DR
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45244
		BUSINESS PHONE:		5132713700
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ballish4120704_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2004-12-07</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000794172</issuerCik>
        <issuerName>MERIDIAN BIOSCIENCE INC</issuerName>
        <issuerTradingSymbol>VIVO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001276478</rptOwnerCik>
            <rptOwnerName>BALLISH GREGORY S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>3471 RIVER HILLS DRIVE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>CINCINNATI</rptOwnerCity>
            <rptOwnerState>OH</rptOwnerState>
            <rptOwnerZipCode>45244</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>VP, Sales and Marketing</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>200</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Option to Buy (Right to Buy Common Stock)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>16.38</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-12-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>7000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2014-12-07</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>7000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>7000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These non-qualified stock options are granted under the Company's 2004 Equity Compensation Plan and will vest over a three
year period commencing at such time as the Company has reported to the public net earnings
of $10,800,000 or greater for fiscal 2005. If net earnings do not reach $10,800,000 or higher for such year, the options
become void. In addition, these stock options are contingent upon shareholder approval of the 2004 Equity Compensation Plan
at the Company's 2005 Annual Meeting and will become void in the absence of such approval.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Melissa Lueke as Attorney in Fact for Gregory S. Ballish</signatureName>
        <signatureDate>2004-12-09</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----